Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults [Phase 3]

View source ↗

Summary

Ipsen's Phase 3 trial is evaluating the effectiveness and safety of Dysport for preventing chronic migraine in adults; the study is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Chronic Migraine | Phase 3 | Status: ACTIVE_NOT_RECRUITING